Clinical Trials
4
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:2
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Not Applicable
1 (25.0%)Phase 2
1 (25.0%)A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease
Phase 1
- Conditions
- Alzheimer Disease
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- VTBIO Co. LTD
- Target Recruit Count
- 12
- Registration Number
- NCT05016427
- Locations
- 🇰🇷
Vtbio Co., Ltd, Seoul, Korea, Republic of
Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen
Not Applicable
Completed
- Conditions
- Stress
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- VTBIO Co. LTD
- Target Recruit Count
- 46
- Registration Number
- NCT03973099
A Safety and Tolerability Study of GB301
Phase 1
- Conditions
- Alzheimer Disease
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- VTBIO Co. LTD
- Target Recruit Count
- 20
- Registration Number
- NCT03865017
- Locations
- 🇦🇺
Bht Lifescience Australia Pty Ltd, Brisbane, Queensland, Australia
Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- VTBIO Co. LTD
- Target Recruit Count
- 151
- Registration Number
- NCT01715350
- Locations
- 🇰🇷
Kyung Hee University Oriental Medicine Hospital, Seoul, Dongdaemun-gu, Korea, Republic of
🇰🇷National Health Insurance Corporation Ilsan Hospital, Goyang, Ilsandong-gu, Korea, Republic of
🇰🇷The Catholic University of Korea, St. Vincent's Hospital, Suwon, Paldal-gu, Korea, Republic of
News
No news found